Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)

NCT04357808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Covid-19

Interventions

DRUG: Sarilumab
OTHER: Standar of care

Sponsor

Maria del Rosario Garcia de Vicuña Pinedo

Collaborators

[object Object]